StockDriftsStockDriftsTop 3 Wildcat Capital Management, LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ULCC | FRONTIER GROUP HLDGS INC | 97.13% | 28.06M | $222.0M | +0.00%(+0) | $6.52(+7.13%) | 2026-06-30 | |
| ALLO | ALLOGENE THERAPEUTICS INC | 2.66% | 2.92M | $6.1M | +0.00%(+0) | $17.33(-87.97%) | 2026-06-30 | |
| CHYM | CHIME FINL INC | 0.21% | 23.9K | $489K | new | $18.94(+64.26%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +29.05% | +114.92% | -3.93% | -18.16% |
| Top 20 Holdings Unweighted | +59.80% | +308.08% | +19.76% | +146.32% |
Wildcat Capital Management, LLC reports $228.53M in US-listed equity holdings across 3 positions in its most recent 13F filing. Its largest disclosed positions are ULCC (97.1%), ALLO (2.7%) and CHYM (0.2%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned +114.92% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Wildcat Capital Management, LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Wildcat Capital Management, LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1582384). View Wildcat Capital Management, LLC’s 13F filings on SEC